Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
    Review

    Ravandi, F.; Kreitman, R. J.; Tiacci, E.; Andritsos, L.; Banerji, V.; Barrientos, J. C.; Bhat, S. A.; Blachly, J. S.; Broccoli, A.; Call, T.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Recent progress in acute leukemia and myelodysplasia
    Review

    Carraway, H. E.; Pollyea, D. A.; Stein, E. M.
    Best Practice and Research: Clinical Haematology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy
    Journal Article

    Handa, S.; Lee, J. O.; Derkach, A.; Stone, R. M.; Saven, A.; Altman, J. K.; Grever, M. R.; Rai, K. R.; Shukla, M.; Vemuri, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Krankheitsmodifizierendes potenzial von pelabresib, demonstriert durch verbesserung der knochenmarkfunktion und dem daraus resultierendem klinischen nutzen bei patienten mit myelofibrose
    Meeting Abstract

    Platzbecker, U.; Vannucchi, A.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R. A.; Rampal, R. K.; Oh, S. T.; Olteanu, H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) monotherapie in myelofibrose: Eine aktualisierung von klinischen und translationalen daten aus der laufenden MANIFEST studie
    Meeting Abstract

    Heidel, F.; Passamonti, F.; Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A. M.; Verstovsek, S.; Harrison, C.; Bose, P.; Schiller, G. J.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Resistenz auf typ II JAK2 inhibition via persistente MAPK aktivierung kann durch MEK inhibition überwunden werden
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J. L.; Wicki, A.; Ghosh, N.; Passweg, J.; Dirnhofer, S.; Levine, R. L.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • 96-Wochen update aus der phase 3 ASCEMBL studie zur untersuchung von sicherheit und wirksamkeit von asciminib vs. bosutinib bei patienten mit chronischer myeloischer leukämie in chronischer phase nach vorbehandlung mit 2 TKI
    Meeting Abstract

    Hochhaus, A.; Réa, D.; Saussele, S.; Buske, S.; Balabanov, S.; Lang, F.; Sauer, T.; Gattermann, N.; Mauro, M.; Minami, Y.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Racial disparities in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Badar, T.; Litzow, M. R.; Shallis, R.; Stahl, M.; Bewersdorf, J. P.; Saliba, A. N.; de Camargo Correia, G. S.; Patel, A. A.; Abaza, Y.; Murthy, G. S. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Prognostic testing and treatment patterns in Black patients (pts) with chronic lymphocytic leukemia (CLL) from the informCLL prospective, observational registry
    Meeting Abstract

    Barrientos, J. C.; Mato, A.; Sharman, J. P.; Brander, D. M.; Gutierrez, M. E.; Wu, L.; Panjabi, S.; Young, A.; Upasani, S.; Naganuma, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Wang, E. S.; Goldberg, A. D.; Walter, R. B.; Collins, R.; Stone, R. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save